Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that a new method can measure caffeine and drugs in hair, finding caffeine abusers have 70 times more caffeine than normal, with a proposed cut-off value for abuse.

New tools and criteria have been developed to better assess and treat pediatric lupus.

Gene expression in hair follicles can help diagnose methamphetamine use disorder.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

Women with PCOS are more likely to develop kidney stones, especially those with certain PCOS types.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Severe and early hair loss may indicate a higher risk of heart disease.

High YKL-40 levels predict early hair loss and hidden metabolic issues.

Fewer GGC sequences in the androgen receptor gene improve finasteride treatment for hair loss.

Obesity is common in PCOS patients and early treatment is important for their heart and metabolic health.

Most cases of high male hormone levels in women are due to polycystic ovary syndrome.

Hair transplants are better for severe hair loss, while scalp micropigmentation suits those with denser hair.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

The HSVS-A is an effective tool for quickly screening hair shedding in Asian women.

High-resolution MRI can distinguish between tertiary androgenetic alopecia and severe alopecia areata by measuring scalp and tissue thickness and hair follicle depth.

The study aims to create a model to predict health attributes using diverse health data from Japanese adults.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

Low zinc levels in chronic liver disease patients are linked to more severe symptoms like taste issues and skin problems, and zinc supplements might help.

Oral Vitamin D can improve hair density and reduce hair loss in Telogen Effluvium patients.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Low PON1 levels may indicate and predict the severity of hair loss.

Finasteride treatment for three years changes certain polyamine levels in the blood but not in urine.

Lower vitamin D levels may contribute to female hair loss.

DNA profiling in forensics has improved, but predicting physical traits and ancestry from DNA has limitations and requires ethical consideration.

DNA variants can predict male pattern baldness, with higher risk scores increasing baldness likelihood.